Ignite Creation Date:
2024-07-17 @ 10:59 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06495918
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-07-03
Brief Title:
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI Axitinib Implant in Subjects With Neovascular Age- Related Macular Degeneration
Sponsor:
Ocular Therapeutix Inc
Organization:
Ocular Therapeutix Inc
Study Overview
Official Title:
A Phase 3 Multicenter Double-Masked Randomized Parallel Group Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI Axitinib Implant in Subjects With Neovascular Age- Related Macular Degeneration
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI Axitinib Implant in Subjects with Neovascular Age- Related Macular Degeneration
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None